S100A10 and ovarian carcinoma: Moreover, high stromal annexin A2 and high cytoplasmic S100A10 expression in serous ovarian cancer tissues are associated with a 3.4-fold increased risk of progression and a 7.9-fold risk of ovarian cancer death [16].